Jones Day's patent dispute practice dedicates itself to two fields; Gerd Jaekel, who is a qualified lawyer and physicist, heads the engineering team while Christian Paul, who is a dual-qualified lawyer and chemist, focuses on the chemistry and pharmaceuticals sector. Due to the firm's international presence, the practice frequently assists with cross-border disputes in cooperation with other locations, for example in the US and France, while its client base  includes numerous global companies.

Legal 500 Editorial commentary

Key clients

  • Akebia Therapeutics, Inc.
  • BioMarin Pharmaceuticals, Inc.
  • Lufthansa Technik AG /Astronics, Panasonic
  • Puma Biotechnology, Inc.
  • Hope Medical Enterprises, Inc.
  • Innio
  • SCHWIND eye-tech-solutions GmbH
  • Tung Thih Electronic (TTE) Co. Ltd. /Valeo
  • Zensun (Shanghai) Sci. & Tech. Co., Ltd.

Work highlights

  • Representation of BioMarin in several opposition appeal proceedings against Alfred E. Tiefenbacher GmbH & Co. KG, Dipharma SA, Teva and Generics [UK] Limited (Mylan).
  • Successfully represented Puma Biotechnology, Inc. in dismissing the opposition to a European patent covering the use of irreversible inhibitors for the treatment of gefiti-nib/erlotinib-resistant cancers as well as cancers harboring the T790M EGFR mutation.
  • Representation of Lufthansa Technik AG / Astronics, Panasonic and others in an international patent infringement lawsuit against a US supplier of cabin electronics.

Practice head

The lawyer(s) leading their teams.

Gerd Jaekel, Christian Paul